The global Integrated Drug Discovery Service market size was valued at US$ 31300 million in 2024 and is forecast to a readjusted size of USD 73790 million by 2031 with a CAGR of 13.2% during review period.
Integrated Drug Discovery Service (IDDS) refers to a comprehensive approach to drug discovery that combines multiple expertise and technologies under one roof, streamlining the entire process from target identification to clinical development. It contrasts with the traditional, more fragmented approach where different stages of drug discovery are often handled by separate companies or research groups.
The Integrated Drug Discovery Service market is experiencing strong and sustained growth, fueled by several key factors:
Market Drivers:
Rising demand for new drugs: The global pharmaceutical industry faces constant pressure to develop new and effective drugs for various diseases. Integrated drug discovery services provide a comprehensive solution, streamlining the drug discovery process and accelerating the development of new therapies.
Focus on efficiency and cost-effectiveness: Pharmaceutical companies are looking for ways to reduce the high costs and risks associated with traditional drug discovery. Integrated services offer a more efficient and cost-effective approach by combining various expertise and technologies under one roof.
Technological advancements: Advancements in areas like artificial intelligence, high-throughput screening, and computational biology are transforming the drug discovery landscape, making integrated services even more powerful and efficient.
Growing complexity of drug targets: Modern drug targets are often complex and require a multidisciplinary approach. Integrated services offer access to a wider range of expertise and technologies to tackle these challenges.
Increased outsourcing: Many pharmaceutical companies are choosing to outsource some or all of their drug discovery efforts to specialized CROs (Contract Research Organizations) offering integrated services, allowing them to focus on core competencies and reduce internal resources.
Market Challenges:
High cost of entry: Setting up and maintaining integrated drug discovery capabilities requires significant investment in infrastructure, technology, and personnel, which can be a barrier for smaller players.
Competition: The market is becoming increasingly competitive, with established CROs and emerging startups vying for market share.
Complexities in managing partnerships: Effective collaboration and communication between pharmaceutical companies and integrated service providers are crucial for success, but managing large and complex partnerships can be challenging.
Regulatory hurdles: Stringent regulations in the pharmaceutical industry require strict compliance with quality and safety standards, which can increase the complexity and cost of providing integrated services.
Integration of data and workflows: Integrating data generated from different platforms and technologies within the integrated drug discovery process requires sophisticated data management strategies and expertise.
Overall, the Integrated Drug Discovery Service market is a dynamic and promising sector with significant growth potential. Technological advancements, an increasing focus on efficiency, and the rising demand for new drugs are driving this market forward. However, challenges like managing complex partnerships, navigating regulatory hurdles, and integrating data and workflows need to be addressed to ensure continued success.
This report is a detailed and comprehensive analysis for global Integrated Drug Discovery Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Integrated Drug Discovery Service market size and forecasts, in consumption value ($ Million), 2020-2031
Global Integrated Drug Discovery Service market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Integrated Drug Discovery Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Integrated Drug Discovery Service market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Integrated Drug Discovery Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Integrated Drug Discovery Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Syngene, Eurofins, Charles River, Evotec, BioAscent, Sygnature Discovery, Jubilant Biosys, Charnwood Molecular, Domainex, Pharmaron, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Integrated Drug Discovery Service market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Ligand Based Drug Discovery
Structure Based Drug Discovery
Others
Market segment by Application
Biotech and Pharmaceutical Companies
Academic Institution
Others
Market segment by players, this report covers
Syngene
Eurofins
Charles River
Evotec
BioAscent
Sygnature Discovery
Jubilant Biosys
Charnwood Molecular
Domainex
Pharmaron
Dalton Pharma Services
Selvita
Metrion Biosciences
WuXi AppTec
Malvern Panalytical
Hitgen
BioDuro
Curia Global
Taros Chemicals
Symeres
Aragen Life Sciences
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Integrated Drug Discovery Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Integrated Drug Discovery Service, with revenue, gross margin, and global market share of Integrated Drug Discovery Service from 2020 to 2025.
Chapter 3, the Integrated Drug Discovery Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Integrated Drug Discovery Service market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Integrated Drug Discovery Service.
Chapter 13, to describe Integrated Drug Discovery Service research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Integrated Drug Discovery Service by Type
1.3.1 Overview: Global Integrated Drug Discovery Service Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Integrated Drug Discovery Service Consumption Value Market Share by Type in 2024
1.3.3 Ligand Based Drug Discovery
1.3.4 Structure Based Drug Discovery
1.3.5 Others
1.4 Global Integrated Drug Discovery Service Market by Application
1.4.1 Overview: Global Integrated Drug Discovery Service Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Biotech and Pharmaceutical Companies
1.4.3 Academic Institution
1.4.4 Others
1.5 Global Integrated Drug Discovery Service Market Size & Forecast
1.6 Global Integrated Drug Discovery Service Market Size and Forecast by Region
1.6.1 Global Integrated Drug Discovery Service Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Integrated Drug Discovery Service Market Size by Region, (2020-2031)
1.6.3 North America Integrated Drug Discovery Service Market Size and Prospect (2020-2031)
1.6.4 Europe Integrated Drug Discovery Service Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Integrated Drug Discovery Service Market Size and Prospect (2020-2031)
1.6.6 South America Integrated Drug Discovery Service Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Integrated Drug Discovery Service Market Size and Prospect (2020-2031)
2 Company Profiles
2.1 Syngene
2.1.1 Syngene Details
2.1.2 Syngene Major Business
2.1.3 Syngene Integrated Drug Discovery Service Product and Solutions
2.1.4 Syngene Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Syngene Recent Developments and Future Plans
2.2 Eurofins
2.2.1 Eurofins Details
2.2.2 Eurofins Major Business
2.2.3 Eurofins Integrated Drug Discovery Service Product and Solutions
2.2.4 Eurofins Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Eurofins Recent Developments and Future Plans
2.3 Charles River
2.3.1 Charles River Details
2.3.2 Charles River Major Business
2.3.3 Charles River Integrated Drug Discovery Service Product and Solutions
2.3.4 Charles River Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Charles River Recent Developments and Future Plans
2.4 Evotec
2.4.1 Evotec Details
2.4.2 Evotec Major Business
2.4.3 Evotec Integrated Drug Discovery Service Product and Solutions
2.4.4 Evotec Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Evotec Recent Developments and Future Plans
2.5 BioAscent
2.5.1 BioAscent Details
2.5.2 BioAscent Major Business
2.5.3 BioAscent Integrated Drug Discovery Service Product and Solutions
2.5.4 BioAscent Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 BioAscent Recent Developments and Future Plans
2.6 Sygnature Discovery
2.6.1 Sygnature Discovery Details
2.6.2 Sygnature Discovery Major Business
2.6.3 Sygnature Discovery Integrated Drug Discovery Service Product and Solutions
2.6.4 Sygnature Discovery Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Sygnature Discovery Recent Developments and Future Plans
2.7 Jubilant Biosys
2.7.1 Jubilant Biosys Details
2.7.2 Jubilant Biosys Major Business
2.7.3 Jubilant Biosys Integrated Drug Discovery Service Product and Solutions
2.7.4 Jubilant Biosys Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Jubilant Biosys Recent Developments and Future Plans
2.8 Charnwood Molecular
2.8.1 Charnwood Molecular Details
2.8.2 Charnwood Molecular Major Business
2.8.3 Charnwood Molecular Integrated Drug Discovery Service Product and Solutions
2.8.4 Charnwood Molecular Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Charnwood Molecular Recent Developments and Future Plans
2.9 Domainex
2.9.1 Domainex Details
2.9.2 Domainex Major Business
2.9.3 Domainex Integrated Drug Discovery Service Product and Solutions
2.9.4 Domainex Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Domainex Recent Developments and Future Plans
2.10 Pharmaron
2.10.1 Pharmaron Details
2.10.2 Pharmaron Major Business
2.10.3 Pharmaron Integrated Drug Discovery Service Product and Solutions
2.10.4 Pharmaron Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Pharmaron Recent Developments and Future Plans
2.11 Dalton Pharma Services
2.11.1 Dalton Pharma Services Details
2.11.2 Dalton Pharma Services Major Business
2.11.3 Dalton Pharma Services Integrated Drug Discovery Service Product and Solutions
2.11.4 Dalton Pharma Services Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Dalton Pharma Services Recent Developments and Future Plans
2.12 Selvita
2.12.1 Selvita Details
2.12.2 Selvita Major Business
2.12.3 Selvita Integrated Drug Discovery Service Product and Solutions
2.12.4 Selvita Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Selvita Recent Developments and Future Plans
2.13 Metrion Biosciences
2.13.1 Metrion Biosciences Details
2.13.2 Metrion Biosciences Major Business
2.13.3 Metrion Biosciences Integrated Drug Discovery Service Product and Solutions
2.13.4 Metrion Biosciences Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Metrion Biosciences Recent Developments and Future Plans
2.14 WuXi AppTec
2.14.1 WuXi AppTec Details
2.14.2 WuXi AppTec Major Business
2.14.3 WuXi AppTec Integrated Drug Discovery Service Product and Solutions
2.14.4 WuXi AppTec Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 WuXi AppTec Recent Developments and Future Plans
2.15 Malvern Panalytical
2.15.1 Malvern Panalytical Details
2.15.2 Malvern Panalytical Major Business
2.15.3 Malvern Panalytical Integrated Drug Discovery Service Product and Solutions
2.15.4 Malvern Panalytical Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Malvern Panalytical Recent Developments and Future Plans
2.16 Hitgen
2.16.1 Hitgen Details
2.16.2 Hitgen Major Business
2.16.3 Hitgen Integrated Drug Discovery Service Product and Solutions
2.16.4 Hitgen Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Hitgen Recent Developments and Future Plans
2.17 BioDuro
2.17.1 BioDuro Details
2.17.2 BioDuro Major Business
2.17.3 BioDuro Integrated Drug Discovery Service Product and Solutions
2.17.4 BioDuro Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 BioDuro Recent Developments and Future Plans
2.18 Curia Global
2.18.1 Curia Global Details
2.18.2 Curia Global Major Business
2.18.3 Curia Global Integrated Drug Discovery Service Product and Solutions
2.18.4 Curia Global Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 Curia Global Recent Developments and Future Plans
2.19 Taros Chemicals
2.19.1 Taros Chemicals Details
2.19.2 Taros Chemicals Major Business
2.19.3 Taros Chemicals Integrated Drug Discovery Service Product and Solutions
2.19.4 Taros Chemicals Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2025)
2.19.5 Taros Chemicals Recent Developments and Future Plans
2.20 Symeres
2.20.1 Symeres Details
2.20.2 Symeres Major Business
2.20.3 Symeres Integrated Drug Discovery Service Product and Solutions
2.20.4 Symeres Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2025)
2.20.5 Symeres Recent Developments and Future Plans
2.21 Aragen Life Sciences
2.21.1 Aragen Life Sciences Details
2.21.2 Aragen Life Sciences Major Business
2.21.3 Aragen Life Sciences Integrated Drug Discovery Service Product and Solutions
2.21.4 Aragen Life Sciences Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2025)
2.21.5 Aragen Life Sciences Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Integrated Drug Discovery Service Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Integrated Drug Discovery Service by Company Revenue
3.2.2 Top 3 Integrated Drug Discovery Service Players Market Share in 2024
3.2.3 Top 6 Integrated Drug Discovery Service Players Market Share in 2024
3.3 Integrated Drug Discovery Service Market: Overall Company Footprint Analysis
3.3.1 Integrated Drug Discovery Service Market: Region Footprint
3.3.2 Integrated Drug Discovery Service Market: Company Product Type Footprint
3.3.3 Integrated Drug Discovery Service Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Integrated Drug Discovery Service Consumption Value and Market Share by Type (2020-2025)
4.2 Global Integrated Drug Discovery Service Market Forecast by Type (2026-2031)
5 Market Size Segment by Application
5.1 Global Integrated Drug Discovery Service Consumption Value Market Share by Application (2020-2025)
5.2 Global Integrated Drug Discovery Service Market Forecast by Application (2026-2031)
6 North America
6.1 North America Integrated Drug Discovery Service Consumption Value by Type (2020-2031)
6.2 North America Integrated Drug Discovery Service Market Size by Application (2020-2031)
6.3 North America Integrated Drug Discovery Service Market Size by Country
6.3.1 North America Integrated Drug Discovery Service Consumption Value by Country (2020-2031)
6.3.2 United States Integrated Drug Discovery Service Market Size and Forecast (2020-2031)
6.3.3 Canada Integrated Drug Discovery Service Market Size and Forecast (2020-2031)
6.3.4 Mexico Integrated Drug Discovery Service Market Size and Forecast (2020-2031)
7 Europe
7.1 Europe Integrated Drug Discovery Service Consumption Value by Type (2020-2031)
7.2 Europe Integrated Drug Discovery Service Consumption Value by Application (2020-2031)
7.3 Europe Integrated Drug Discovery Service Market Size by Country
7.3.1 Europe Integrated Drug Discovery Service Consumption Value by Country (2020-2031)
7.3.2 Germany Integrated Drug Discovery Service Market Size and Forecast (2020-2031)
7.3.3 France Integrated Drug Discovery Service Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Integrated Drug Discovery Service Market Size and Forecast (2020-2031)
7.3.5 Russia Integrated Drug Discovery Service Market Size and Forecast (2020-2031)
7.3.6 Italy Integrated Drug Discovery Service Market Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Integrated Drug Discovery Service Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Integrated Drug Discovery Service Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Integrated Drug Discovery Service Market Size by Region
8.3.1 Asia-Pacific Integrated Drug Discovery Service Consumption Value by Region (2020-2031)
8.3.2 China Integrated Drug Discovery Service Market Size and Forecast (2020-2031)
8.3.3 Japan Integrated Drug Discovery Service Market Size and Forecast (2020-2031)
8.3.4 South Korea Integrated Drug Discovery Service Market Size and Forecast (2020-2031)
8.3.5 India Integrated Drug Discovery Service Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Integrated Drug Discovery Service Market Size and Forecast (2020-2031)
8.3.7 Australia Integrated Drug Discovery Service Market Size and Forecast (2020-2031)
9 South America
9.1 South America Integrated Drug Discovery Service Consumption Value by Type (2020-2031)
9.2 South America Integrated Drug Discovery Service Consumption Value by Application (2020-2031)
9.3 South America Integrated Drug Discovery Service Market Size by Country
9.3.1 South America Integrated Drug Discovery Service Consumption Value by Country (2020-2031)
9.3.2 Brazil Integrated Drug Discovery Service Market Size and Forecast (2020-2031)
9.3.3 Argentina Integrated Drug Discovery Service Market Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Integrated Drug Discovery Service Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Integrated Drug Discovery Service Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Integrated Drug Discovery Service Market Size by Country
10.3.1 Middle East & Africa Integrated Drug Discovery Service Consumption Value by Country (2020-2031)
10.3.2 Turkey Integrated Drug Discovery Service Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Integrated Drug Discovery Service Market Size and Forecast (2020-2031)
10.3.4 UAE Integrated Drug Discovery Service Market Size and Forecast (2020-2031)
11 Market Dynamics
11.1 Integrated Drug Discovery Service Market Drivers
11.2 Integrated Drug Discovery Service Market Restraints
11.3 Integrated Drug Discovery Service Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Integrated Drug Discovery Service Industry Chain
12.2 Integrated Drug Discovery Service Upstream Analysis
12.3 Integrated Drug Discovery Service Midstream Analysis
12.4 Integrated Drug Discovery Service Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Syngene
Eurofins
Charles River
Evotec
BioAscent
Sygnature Discovery
Jubilant Biosys
Charnwood Molecular
Domainex
Pharmaron
Dalton Pharma Services
Selvita
Metrion Biosciences
WuXi AppTec
Malvern Panalytical
Hitgen
BioDuro
Curia Global
Taros Chemicals
Symeres
Aragen Life Sciences
听
听
*If Applicable.
